Autres langues First Wave BioPharma, Inc.

Actions

FWBI

US33749P4081

Temps Différé Nasdaq Autres places de cotation 19:26:43 03/05/2024			Varia. 5j.	Varia. 1 janv.
2,7 ^USD	-3,23%		-1,46%	-35,71%

29/03	First Wave BioPharma, Inc. déclare ses résultats pour l'année complète clôturée le 31 décembre 2023	CI
14/03	Mise à jour sectorielle : Les actions du secteur de la santé reculent en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	24/04
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	17/04
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	15/04
First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	18/03
Sector Update: Health Care Stocks Retreating Late Afternoon	14/03
Sector Update: Health Care	14/03
First Wave BioPharma Shares Fall After Acquiring ImmunogenX	14/03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Inflation Data	14/03
First Wave Biopharma, Inc. Announces Management Changes	14/03
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline	14/03
First Wave BioPharma, Inc. completed the acquisition of ImmunogenX, LLC for approximately $3 million.	13/03
First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference	05/03
First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering	04/03
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024	13/02
First Wave BioPharma to Present at the DealFlow MicroCap Conference	23/01
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico	17/01
Bull Run 2024: Biopharma Healthcare Stocks Surge, Gaining Momentum: DYAI, ABVC, FWBI, VTAK, NEXI	08/01
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024	04/01
Top Premarket Gainers	03/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues First Wave BioPharma, Inc.

Actions

FWBI

US33749P4081

Autres langues

Filtres